Highlights
NASDAQ: BCLI       Brainstorm Cell
Last Price Today's Change   Day's Range   Trading Volume
5.09   -0.01 (0.20%)  5.00 - 5.16  372,965

Overview

 
Avg Volume (4 weeks):719,065
4 Weeks Range:4.00 - 6.77
4 Weeks Price Volatility (%):
39.35%
52 Weeks Range:3.43 - 10.00
52 Weeks Price Volatility (%):
25.27%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is a developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3799  2095  243  2880 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.17-0.001 
 CELG 108.24+0.11 
 F 5.37+0.34 
 MFA 1.98+0.21 
 CCL 12.42+0.43 
 GE 7.14-0.16 
 BAC 24.86+1.41 
 AAL 12.51+1.18 
 OXY 15.36-0.20 
 ACHN 6.760.00 
Partners & Brokers